AACR meeting
This article was originally published in The Tan Sheet
Executive Summary
American Association for Cancer Research's annual meeting will take place July 11-14 at the Washington Convention Center in Washington, D.C., according to notice posted on group's 1Web site April 23. Initially scheduled to occur April 5-9 in Toronto, the meeting was postponed due to concerns about SARS. Research slated for presentation at the meeting includes a report on weekly NSAID use and its effect on reducing breast cancer incidence, study finding black cohosh may increase chemotherapy drugs' effectiveness (2"The Tan Sheet" April 21, 2003, p. 16)...
You may also be interested in...
American Association For Cancer Research In Brief
The AACR annual meeting, scheduled to be held in Toronto April 5-9, was cancelled due to concerns about the SARS outbreak. However, research abstracts were still submitted to the association.
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.